David Rechtman, VP Medical Affairs Headshot

David J Rechtman, M.D.

VP, Medical Affairs

Dr. Rechtman received his M.D. from State University of New York - Downstate Medical Center College of Medicine. Following a residency in internal medicine and a fellowship in infectious diseases he served on the faculty of SUNY-Health Science Center at Brooklyn while helping to establish and lead the multi-disciplinary AIDS care team at the affiliated Kings County Hospital.

 

Upon deciding to pursue a career in industry, Dr. Rechtman was employed at Baxter Healthcare Corporation’s Hyland Division where he was responsible for product safety for the entire product line and medical affairs for immunological and infectious disease products. While at Hyland, he was instrumental in popularizing a highly effective therapy for a serious complication of bone marrow transplantation, as well as helping to achieve new indications for existing products. Subsequently, Dr. Rechtman spent several years as Medical Director for Ribi Immunochem Research Inc. where he was the Medical Officer for the first phase III trial of a commercial therapeutic cancer vaccine, which was targeted against malignant melanoma. That product was subsequently successfully licensed in Canada. He also directed the team developing a product for the prevention of sepsis in high- risk patients.

 

For the better part of a decade, Dr. Rechtman provided consulting services to various pharmaceutical and biotech companies. These activities subsequently developed into a successful contract research organization that designed and ran clinical trials in the U.S. and abroad. Dr. Rechtman has been an invited speaker at professional gatherings in the U.S. and Europe, has published original research and written chapters for several textbooks, and has given guest lectures to undergraduate and graduate university students in the areas of infectious and immunological diseases and therapies and their development.